Global Immunohistochemistry Market: Projected Growth to $4.7 Billion by 2028

-

In 2023, the global immunohistochemistry market revenue is estimated at $3.2 billion, with a projected growth to $4.7 billion by 2028, representing a CAGR of 7.4% from 2023 to 2028. This market analysis delves into industry trends, pricing, patents, key stakeholders, and consumer behavior. The market's growth is driven by factors such as the aging population, increasing cancer prevalence, advanced IHC technology, reimbursement availability, and digital pathology adoption. Nonetheless, market growth is hindered by alternative technologies and industry consolidation, along with stringent regulatory requirements and a lack of standardization.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121632939

Kits Segment Leads Growth: In 2022, the kits segment experienced the highest growth rate in the immunohistochemistry market. This surge is attributed to the demand for comprehensive solutions from a single, dependable provider. Ready-to-use kits simplify the IHC process and are increasingly favored by diagnostic labs, hospitals, and research institutes.

Forensics Application Segment: Within the market's application segments, forensics accounted for the smallest share in 2022. Although IHC plays a role in determining causes of death in forensics, its applications are primarily limited to identifying natural diseases due to tissue degradation when post-mortem analysis is delayed.

Key Market Players: The global immunohistochemistry market is highly competitive, with key players including F. Hoffmann-La Roche AG, Danaher Corporation, and Agilent Technologies, Inc. These players are expanding their presence through strategic partnerships, product launches, and approvals.

  • F. Hoffmann-La Roche AG (Roche): Roche operates in the IHC market through its Pathology Lab segment, offering products like BenchMark ULTRA IHC/ISH System and OptiView DAB IHC Detection Kit (OptiView). Roche's contribution to the IHC market has made it a prominent player.

  • Danaher Corporation: Danaher, a global science and technology company, provides IHC products through its subsidiary, Leica Biosystems. Their focus on technology-enabled solutions, R&D investments, and comprehensive product lines is driving their market share growth.

Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=121632939

Driver: Adoption of Digital Pathology Fueling Market Growth

Digital pathology systems are increasingly being utilized by healthcare professionals across the globe due to the ongoing trend of automation of diagnostic laboratory processes across major healthcare markets. Digital immunohistochemistry (IHC) integrates traditional IHC staining with digital imaging and analysis tools, facilitating the conversion of stained tissue slides into electronic images that can be remotely accessed, analyzed, and stored, eliminating the reliance on physical slides and enabling efficient collaboration among pathologists and researchers. The advantages of digital pathology application in IHC is that it eliminates physical slide handling and storage, facilitates remote collaboration among pathologists for case sharing and second opinions, enables objective and standardized quantitative analysis of staining, and allows efficient archiving and integration of digital images with other data for comprehensive analysis and research. The major players offering digital IHC are F. Hoffmann-La Roche AG, Leica Biosystems (Danaher Corporation), and Agilent Technologies.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more